Merck to seek emergency authorization for oral Covid treatment after ‘compelling results’ in trials
October 01, 2021 at 06:05 AM EDT
Merck and Ridgeback Biotherapeutics will seek emergency authorization for their drug, which they say could have “a profound impact in controlling the pandemic.”
